Clin Exp Hypertens. 2026 Dec 31;48(1):2610587. doi: 10.1080/10641963.2025.2610587. Epub 2026 Jan 1.ABSTRACTOBJECTIVE: Perivascular adipose tissue (PVAT) is closely related to the pathogenesis of vascular remodeling in hypertension. The objective of this study was to explore the specific molecular me
Eur J Public Health. 2025 Dec 31:ckaf203. doi: 10.1093/eurpub/ckaf203. Online ahead of print.ABSTRACTThe implementation of emergency care networks for ST-elevation myocardial infarction (STEMI), like Codi IAM in Catalonia, has reduced time to reperfusion. We hypothesized that Codi IAM would decrease
Open Respir Arch. 2025 Nov 17;8(1):100522. doi: 10.1016/j.opresp.2025.100522. eCollection 2026 Jan-Mar.ABSTRACTINTRODUCTION: Hypertension is the leading cause of cardiovascular disease, with nocturnal blood pressure (BP) abnormalities (nocturnal hypertension and non-dipping BP) linked to heightened
J Alzheimers Dis Rep. 2025 Dec 29;9:25424823251407541. doi: 10.1177/25424823251407541. eCollection 2025 Jan-Dec.ABSTRACTBACKGROUND: We demonstrated that low-intensity pulsed ultrasound (LIPUS) therapy tended to ameliorate cognitive declines in patients with early Alzheimer's disease (AD) in the pilo
Front Cardiovasc Med. 2025 Dec 16;12:1713387. doi: 10.3389/fcvm.2025.1713387. eCollection 2025.ABSTRACTHigh-density lipoprotein (HDL) has earned its reputation as "good" cholesterol in cardiovascular health, primarily because of its strong inverse association with cardiovascular disease. A potential
Front Cardiovasc Med. 2025 Dec 16;12:1659228. doi: 10.3389/fcvm.2025.1659228. eCollection 2025.ABSTRACTAtherosclerosis, driven primarily by cumulative exposure to low-density lipoprotein cholesterol (LDL-C), is the major cause of atherosclerotic cardiovascular disease (ASCVD). This narrative review
Front Genet. 2025 Dec 16;16:1673314. doi: 10.3389/fgene.2025.1673314. eCollection 2025.ABSTRACTBACKGROUND: Heart failure (HF) is the final stage of cardiovascular diseases. Nicotinamide metabolism (NMN) plays a key role in cardiovascular dysfunction. We aimed to explore genes correlated with NM path
Case Rep Pathol. 2025 Dec 29;2025:7134352. doi: 10.1155/crip/7134352. eCollection 2025.ABSTRACTThis case details a 78-year-old male with a history of old myocardial infarction and chronic myeloid leukemia treated with tyrosine kinase inhibitors (TKIs). The patient presented with exertional dyspnea a
Case Rep Vet Med. 2025 Dec 28;2025:9959506. doi: 10.1155/crve/9959506. eCollection 2025.ABSTRACTAdvances in veterinary diagnostics and treatment have increased awareness of cardiovascular diseases in pet rabbits, with age-related conditions such as valvular disorders becoming more common as these an
Atheroscler Plus. 2025 Dec 4;62:53-61. doi: 10.1016/j.athplu.2025.11.004. eCollection 2025 Dec.ABSTRACTBACKGROUND AND AIMS: Hypercholesterolemia is a major risk factor for atherosclerotic cardiovascular disease. Innate immune cells, including monocytes and neutrophils, play important roles in the pa
Int J Nanomedicine. 2025 Dec 26;20:15813-15826. doi: 10.2147/IJN.S547434. eCollection 2025.ABSTRACTPURPOSE: Rapid and accurate detection of acute heart failure (AHF) enables effective treatment of HF. This study aimed to to establish a timely test using colloidal selenium for initial screening and r
Int J Nanomedicine. 2025 Dec 25;20:15705-15721. doi: 10.2147/IJN.S558039. eCollection 2025.ABSTRACTBACKGROUND: In the microenvironment of atherosclerosis (AS), low-density lipoprotein (LDL) accumulates in injured endothelial areas and undergoes oxidation, thereby generating oxidized LDL (ox-LDL). Th
Cardiol Plus. 2025 Oct-Dec;10(4):253-260. doi: 10.1097/CP9.0000000000000135. Epub 2025 Dec 30.ABSTRACTBACKGROUND AND PURPOSE: With the widespread application of immune checkpoint inhibitors (ICIs) in cancer treatment, the associated risk of developing atherosclerotic cardiovascular injury is increas
Biophys Rep. 2025 Dec 31;11(6):393-407. doi: 10.52601/bpr.2025.240063.ABSTRACTIncreased extracellular matrix (ECM) stiffness, a hallmark of risk in cardiovascular disease (CVD), is closely associated with inflammation triggered by immune cell infiltration in the vessel wall. While numerous immunothe
Ther Clin Risk Manag. 2025 Dec 26;21:1833-1845. doi: 10.2147/TCRM.S563768. eCollection 2025.ABSTRACTOBJECTIVE: Pulmonary vein isolation (PVI) remains the cornerstone of catheter ablation for atrial fibrillation (AF); however, a substantial proportion of patients with non-paroxysmal AF (non-PAF) expe
Cureus. 2025 Nov 30;17(11):e98140. doi: 10.7759/cureus.98140. eCollection 2025 Nov.ABSTRACTSodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes mellitus, work by blocking SGLT2 proteins in the proximal convoluted tubules of the nephrons, thereby preventing
Cureus. 2025 Nov 29;17(11):e98076. doi: 10.7759/cureus.98076. eCollection 2025 Nov.ABSTRACTSystemic lupus erythematosus is an autoimmune disorder involving autoantibody production and immune complex-mediated damage of multiple organ systems, including the heart. The complex systemic manifestations o
Cureus. 2025 Nov 30;17(11):e98156. doi: 10.7759/cureus.98156. eCollection 2025 Nov.ABSTRACTBackground Coronavirus disease 2019 (COVID-19) has been associated with significant cardiovascular complications. While most studies focus on patients with pre-existing cardiac conditions, less is known about
Acta Pharm Sin B. 2025 Dec;15(12):6461-6477. doi: 10.1016/j.apsb.2025.09.035. Epub 2025 Sep 24.ABSTRACTAtherosclerosis is a chronic vascular disease closely associated with endothelial dysfunction. Ferroptosis, a major factor in endothelial dysfunction, plays a pivotal role in the progression of ath
Mater Des. 2025 Dec;260:115013. doi: 10.1016/j.matdes.2025.115013. Epub 2025 Oct 30.ABSTRACTBioresorbable stents were conceived to revolutionize the treatment of cardiovascular diseases. However, their significant benefits were overshadowed by a higher clotting rate compared to permanent implants. T
Front Public Health. 2025 Dec 16;13:1688700. doi: 10.3389/fpubh.2025.1688700. eCollection 2025.ABSTRACTBACKGROUND: Pediatric cardiovascular diseases (CVDs), including congenital heart anomalies (CHAs), rheumatic heart disease (RHD), and related conditions, remain a significant health challenge in In
Front Public Health. 2025 Dec 16;13:1611853. doi: 10.3389/fpubh.2025.1611853. eCollection 2025.ABSTRACTEffective leadership in research and public health is critical to strengthen evidence generation and translation into policy and practice. Mentorship in research and public health is critical to de
Int J Hypertens. 2025 Dec 18;2025:8430910. doi: 10.1155/ijhy/8430910. eCollection 2025.ABSTRACTObstructive sleep apnea (OSA) has been established as one of the independent risk factors for hypertension, and its coexistence substantially raises the risk of cardiovascular incidents. However, existing
Int J Hypertens. 2025 Dec 12;2025:9951414. doi: 10.1155/ijhy/9951414. eCollection 2025.ABSTRACTB-Type natriuretic peptide (BNP) levels below contemporary thresholds for diagnosing congestive heart failure are associated with subclinical heart disease (SHD) and adverse cardiovascular outcomes in comm
